Extended-release opioids for the management of chronic non-malignant pain

By Sloan Paul   Babul Najib  

Expert Opinion on Drug Delivery, Vol. 3, Iss. 4, 2006-07 ,pp. : 489-497

Informa Healthcare

Access to resources Recommend Favorite

Management of Overactive Bladder: Defining the Role of Extended-Release Tolterodine

By Keam S.J.   Perry C.M.  

Disease Management & Health Outcomes, Vol. 12, Iss. 2, 2004-01 ,pp. : 121-142

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison

By Erder M. Haim  

Applied Health Economics and Health Policy, Vol. 10, Iss. 6, 2012-11 ,pp. : 381-395

Adis International

Access to resources Recommend Favorite

Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications

By Jaspart Séverine   Piel Géraldine   Delattre Luc   Evrard Brigitte  

Expert Opinion on Drug Delivery, Vol. 2, Iss. 1, 2005-01 ,pp. : 75-87

Informa Healthcare

Access to resources Recommend Favorite

Formulation development and evaluation of lamivudine controlled release tablets using cross-linked sago starch

By Singh Akhilesh Vikram   Nath Lila Kanta  

Expert Opinion on Drug Delivery, Vol. 10, Iss. 2, 2013-02 ,pp. : 173-182

Informa Healthcare

Access to resources Recommend Favorite